187
Views
2
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

A Simplified Screening Protocol Predicts Pathological Electroneurographic Results in Patients with Suspected Polyneuropathy

, , , &
Pages 28-35 | Received 20 Aug 2009, Published online: 03 Feb 2010

REFERENCES

  • Boulton, A. J., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004). Diabetic somatic neuropathies. Diabetes Care, 27(6), 1458–1486.
  • Boulton, A. J., Vileikyte, L., Ragnarson-Tennvall, G., & Apelqvist, J. (2005). The global burden of diabetic foot disease. Lancet, 366(9498), 1719–1724.
  • Cocito, D., Paolasso, I., Pazzaglia, C., Tavella, A., Poglio, F., Ciaramitaro, P., (2006). Pain affects the quality of life of neuropathic patients. Neurological Sciences, 27(3), 155–160.
  • Costa, L. A., Maraschin, J. F., Xavier de Castro, J. H., Gross, J. L., & Friedman, R. (2006). A simplified protocol to screen for distal polyneuropathy in type 2 diabetic patients. Diabetes Research and Clinical Practice, 73(3), 292–297.
  • Dyck, P. J., Karnes, J. L., Daube, J., O’Brien, P., & Service, F. J. (1985). Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain, 108(Pt 4), 861–880.
  • Dyck, P. J., Karnes, J., O’Brien, P. C., & Swanson, C. J. (1986). Neuropathy symptom profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis. Neurology, 36(10), 1300–1308.
  • Feldman, E. L., Stevens, M. J., Thomas, P. K., Brown, M. B., Canal, N., & Greene, D. A. (1994). A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care, 17(11), 1281–1289.
  • Gibbons, C. H., Griffin, J. W., Polydefkis, M., Bonyhay, I., Brown, A., Hauer, P. E., (2006). The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy. Neurology, 66(2), 256–258.
  • Herder, C., Lankisch, M., Ziegler, D., Rathmann, W., Koenig, W., Illig, T., . (2009). Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA survey F3 (Augsburg/Germany). Diabetes Care, 52(3), 680–682.
  • Herrmann, D. N., Ferguson, M. L., Pannoni, V., Barbano, R. L., Stanton, M., & Logigian, E. L. (2004). Plantar nerve AP and skin biopsy in sensory neuropathies with normal routine conduction studies. Neurology, 63(5), 879–885.
  • Holland, N. R., Crawford, T. O., Hauer, P., Cornblath, D. R., Griffin, J. W., & McArthur, J. C. (1998). Small-fiber sensory neuropathies: Clinical course and neuropathology of idiopathic cases. Annals of Neurology, 44(1), 47–59.
  • Johnsen, B., & Fuglsang-Frederiksen, A. (2000). Electrodiagnosis of polyneuropathy. Neurophysiologie Clinique, 30(6), 339– 351.
  • Krarup, C. (2003). An update on electrophysiological studies in neuropathy. Current Opinion in Neurology, 16(5), 603–612.
  • Loseth, S., Lindal, S., Stalberg, E., & Mellgren, S. I. (2006). Intraepidermal nerve fibre density, quantitative sensory testing and nerve conduction studies in a patient material with symptoms and signs of sensory polyneuropathy. European Journal of Neurology, 13(2), 105–111.
  • Lunetta, M., Le Moli, R., Grasso, G., & Sangiorgio, L. (1998). A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy. Diabetes Research and Clinical Practice, 39(3), 165–172.
  • Malik, R. A., Tesfaye, S., Newrick, P. G., Walker, D., Rajbhandari, S. M., Siddique, I., (2005). Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia, 48(3), 578–585.
  • Moghtaderi, A., Bakhshipour, A., & Rashidi, H. (2006). Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clinical Neurology and Neurosurgery, 108(5), 477–481.
  • Neundörfer, B. (2006). Polyneuropathien ( Vol. Auflage: 1). Stuttgard, Germany: Thieme.
  • Olaleye, D., Perkins, B. A., & Bril, V. (2001). Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Research and Clinical Practice, 54(2), 115–128.
  • Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Summary and recommendations. (1992). Neurology, 42(9), 1837–1839.
  • Reiber, G. E., Vileikyte, L., Boyko, E. J., del Aguila, M., Smith, D. G., Lavery, L. A., . (1999). Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care, 22(1), 157–162.
  • Rosenberg, N. R., Slotema, C. W., Hoogendijk, J. E., & Vermeulen, M. (2005). Follow up of patients with signs and symptoms of polyneuropathy not confirmed by electrophysiological studies. Journal of neurology, neurosurgery, and Psychiatry, 76(6), 879–881.
  • Scherens, A., Maier, C., Haussleiter, I. S., Schwenkreis, P., Vlckova-Moravcova, E., Baron, R., (2008). Painful or painless lower limb dysesthesias are highly predictive of peripheral neuropathy: Comparison of different diagnostic modalities. European Journal of Pain, 13(7), 711–718.
  • Valk, G. D., Grootenhuis, P. A., van Eijk, J. T., Bouter, L. M., & Bertelsmann, F. W. (2000). Methods for assessing diabetic polyneuropathy: Validity and reproducibility of the measurement of sensory symptom severity and nerve function tests. Diabetes Research and Clinical Practice, 47(2), 87–95.
  • Veves, A., Manes, C., Murray, H. J., Young, M. J., & Boulton, A. J. (1993). Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care, 16(8), 1187–1189.
  • Westblad, M. E., Forsberg, A., & Press, R. (2009). Disability and health status in patients with chronic inflammatory demyelinating polyneuropathy. Disability and Rehabilitation, 31(9), 720–725.
  • Young, M. J., Boulton, A. J., MacLeod, A. F., Williams, D. R., & Sonksen, P. H. (1993). A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia, 36(2), 150–154.
  • Ziegler, D., Pritchett, Y. L., Wang, F., Desaiah, D., Robinson, M. J., Hall, J. A., (2007). Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain. Diabetes Care, 30(3), 664–669.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.